AWM Investment Company Inc. Has $13.43 Million Stake in OrthoPediatrics Corp. $KIDS

Key Points

• AWM Investment Company Inc. has increased its stake in OrthoPediatrics Corp. by 5.5%, acquiring an additional 28,488 shares, bringing its total ownership to 545,282 shares valued at approximately $13.43 million.
• Multiple hedge funds have significantly increased their positions in OrthoPediatrics, with GAMMA Investing LLC boosting its stake by 4,618.2% and others like Dimensional Fund Advisors LP and Deutsche Bank AG also expanding their holdings.
• Research firms have varied opinions on OrthoPediatrics, with target prices ranging from $30.00 to $42.00, while the stock currently trades around $20.80, reflecting a decrease of 2.6%.

AWM Investment Company Inc. lifted its position in shares of OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) by 5.5% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 545,282 shares of the company's stock after buying an additional 28,488 shares during the quarter. OrthoPediatrics comprises 1.8% of AWM Investment Company Inc.'s holdings, making the stock its 20th biggest position. AWM Investment Company Inc. owned 2.25% of OrthoPediatrics worth $13,430,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Birchview Capital LP acquired a new position in OrthoPediatrics in the first quarter valued at about $493,000. PDT Partners LLC acquired a new position in OrthoPediatrics in the first quarter valued at about $244,000. Paradigm Capital Management Inc. NY raised its stake in OrthoPediatrics by 1,607.0% in the first quarter. Paradigm Capital Management Inc. NY now owns 170,700 shares of the company's stock valued at $4,204,000 after purchasing an additional 160,700 shares in the last quarter. American Century Companies Inc. raised its stake in OrthoPediatrics by 16.1% in the first quarter. American Century Companies Inc. now owns 30,658 shares of the company's stock valued at $755,000 after purchasing an additional 4,248 shares in the last quarter. Finally, Nuveen LLC acquired a new position in OrthoPediatrics in the first quarter valued at about $921,000. Institutional investors and hedge funds own 69.05% of the company's stock.

Insider Transactions at OrthoPediatrics

In other OrthoPediatrics news, CFO Fred Hite purchased 5,076 shares of the company's stock in a transaction on Thursday, August 21st. The shares were purchased at an average cost of $19.41 per share, with a total value of $98,525.16. Following the completion of the purchase, the chief financial officer owned 213,065 shares in the company, valued at $4,135,591.65. This represents a 2.44% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 31.80% of the company's stock.

OrthoPediatrics Trading Down 0.6%

Shares of NASDAQ:KIDS traded down $0.14 during midday trading on Monday, hitting $20.78. 41,696 shares of the stock were exchanged, compared to its average volume of 193,908. The stock has a market capitalization of $520.83 million, a price-to-earnings ratio of -11.55 and a beta of 1.06. The company has a debt-to-equity ratio of 0.27, a quick ratio of 3.43 and a current ratio of 6.66. The business's 50-day moving average price is $21.09 and its 200 day moving average price is $21.97. OrthoPediatrics Corp. has a 12 month low of $16.59 and a 12 month high of $33.14.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported ($0.11) EPS for the quarter, beating the consensus estimate of ($0.17) by $0.06. OrthoPediatrics had a negative return on equity of 6.36% and a negative net margin of 18.92%.The business had revenue of $61.08 million for the quarter, compared to analysts' expectations of $61.40 million. OrthoPediatrics has set its FY 2025 guidance at EPS. Analysts predict that OrthoPediatrics Corp. will post -0.93 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the company. Citigroup reaffirmed a "market outperform" rating on shares of OrthoPediatrics in a research note on Friday, August 8th. Wall Street Zen upgraded OrthoPediatrics from a "sell" rating to a "hold" rating in a research report on Saturday, August 9th. BTIG Research decreased their target price on OrthoPediatrics from $40.00 to $39.00 and set a "buy" rating on the stock in a research report on Wednesday, August 6th. Finally, JMP Securities set a $35.00 target price on OrthoPediatrics and gave the company a "market outperform" rating in a research report on Friday, August 8th. Seven research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $34.14.

OrthoPediatrics Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.